PETALING JAYA: The Healthcare National Key Economic Area (NKEA) will aim to realise seven critical targets set for this year, including the implementation of an Off-take Agreement Incentive of Medical Devices by mid-2014.
Under Malaysian pharmaceuticals (Entry Point Project 3 ( EPP3)), Hovid Berhad aims to start construction of a new plant in early 2014 to expand its tablet and capsule production capacity, allowing it to target development and production of new off-patent drugs for supply to the Health Ministry and its export markets.